Stratified Medicine and Reimbursement Issues

Stratified Medicine and Reimbursement Issues

Stratified Medicine (SM) has the potential to target patient populations who will most benefit from a therapy while reducing unnecessary health interventions associated with side effects. The link between clinical biomarkers/diagnostics and therapies provides new opportunities for value creation to...

Full description

Bibliographic Details
Main Authors: Hans-Joerg eFugel, Mark eNuijten, Maarten ePostma
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-10-01
Series:Frontiers in Pharmacology
Subjects:
Biomarkers, Pharmacological
diagnostics
reimbursement
Stratified Medicine
Health Technology Assessment
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00181/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00181/full

Similar Items